EMN:NYSEEastman Chemical Company Analysis
Data as of 2026-06-17 - not real-time
$73.51
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Eastman Chemical is trading just above a key support level while the short‑term moving average sits above the longer‑term average, hinting at a still‑intact bullish trend. However, the MACD histogram is slightly negative and the signal line sits above the MACD line, introducing short‑term bearish pressure. The RSI hovers around the midpoint, suggesting the stock is neither overbought nor oversold. Volatility over the past month is elevated, and trading volume has been on a downtrend, which could amplify price swings. The dividend yield remains high, but the payout ratio is approaching 100%, raising questions about sustainability. A discounted cash flow model flags a fair value far below the current market price, indicating potential overvaluation from a cash‑flow perspective. Revenue has been contracting, and the company carries a substantial debt load that dwarfs its equity base, adding leverage risk. Operating margins are modest, and the chemical sector faces heightened regulatory scrutiny, especially in environmentally sensitive markets. Despite a strong dividend, the combination of high leverage, declining sales, and a price premium relative to intrinsic estimates creates a cautious outlook. Investors should weigh the attractive yield against the sustainability concerns and the technical signs of short‑term weakness.
In summary, while the stock shows some defensive characteristics, the underlying fundamentals and valuation signals suggest limited upside, and the risk of dividend cuts or further price pressure remains notable.
In summary, while the stock shows some defensive characteristics, the underlying fundamentals and valuation signals suggest limited upside, and the risk of dividend cuts or further price pressure remains notable.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish MACD divergence
- Price near recent support
- Decreasing trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Revenue contraction and high leverage
- Attractive but potentially unsustainable dividend
- Forward earnings multiple suggests modest upside
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- DCF valuation indicates significant overprice
- Elevated debt-to-equity ratio
- Regulatory and environmental headwinds in the specialty chemicals sector
Key Metrics & Analysis
Financial Health
Revenue Growth-4.90%
Profit Margin4.62%
P/E Ratio21.2
ROE6.63%
ROA3.53%
Debt/Equity89.62
P/B Ratio1.4
Op. Cash Flow$1.0B
Free Cash Flow$434.0M
Technical Analysis
TrendBullish
RSI49.6
Support$67.82
Resistance$77.13
MA 20$73.91
MA 50$73.55
MA 200$68.50
MACDBearish
VolumeDecreasing
Fear & Greed Index90.84
Valuation
Fair Value$8.22
Target Price$84.33
Upside/Downside14.72%
GradeOvervalued
TypeValue
Dividend Yield4.59%
Risk Assessment
Beta1.19
Volatility31.80%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.